Stock Expert AI

Content generated by AI editorial engine. Editorially supervised by Sedat ANAK.

Globe Life Inc.
GL - NYSE - $151.08 (as of ) ▼ -0.90%
-
Earnings Wed 22 Jul
Note: this preview was published before the 2026-07-22 earnings report. Results have since been released — verify against the latest filings.

Globe Life Inc. (GL) Q2 FY26 earnings preview — archived, published May 9, 2026

The median of 2 price targets is $172[FMP target], stock is $151, +13.5% vs the analyst consensus median. Q1 FY26 EPS $3.43 vs $3.46 estimate: miss (-0.9%)[FMP earnings]. Stock move on D+1: +1.8%.

↓ summary below
Quick Take - in 40 seconds ·
A
Council 3/6 - Historical V1 score 53

A — FMP rating [FMP ratings]. Form 4: unavailable[FMP Form 4].

Quick Answer

Globe Life Inc. (GL) Q2 consensus: revenue $1.6B[FMP est], EPS $3.68[FMP est]. 0 consecutive quarters of beat[FMP earnings].

Detailed analysis below ↓
$3.68 EPS Estimate Last year $3.27 - +13% YoY
0 Beat Streak Expectations beaten consecutively for the last 0 quarters

Q1 FY26 EPS $3.43 vs $3.46 estimate: miss (-0.9%)[FMP]. Stock move on D+1: +1.8%[FMP D+1].

Watchlist

4 metrics stand out this quarter.

14% Expectation / Guide

Health Premium Growth Guidance

health_premium_growth_guidance

Globe Life expects health premium revenue to grow in the range of 14% to 17% for the year.

"For the year, we expect health premium revenue to grow in the range of 14% to 17%."

- Frank Svoboda - Q1 FY26 Earnings Call - April 23, 2026
3% Expectation / Guide

Life Premium Growth Guidance

life_premium_growth_guidance

Globe Life expects life premium revenue to grow between 3% and 3.5% for the year 2026.

"For the year, we expect life premium revenue to grow between 3% and 3.5%."

- Frank Svoboda - Q1 FY26 Earnings Call - April 23, 2026
7% Expectation / Guide

Premium Revenue Growth Guidance

premium_revenue_growth_guidance

Globe Life expects total premium revenue to grow approximately 7% for the full year 2026.

"For the full year, we expect total premium revenue to grow approximately 7%."

- Frank Svoboda - Q1 FY26 Earnings Call - April 23, 2026
$560 million Investor Focus

Share Repurchase Increase

share_repurchase_increase

Globe Life has increased the range for anticipated share repurchases to $560 million to $610 million for the full year 2026.

"In addition, we have increased the range for anticipated share repurchases to $560 million to $610 million for the full year."

- Thomas Kalmbach - Q1 FY26 Earnings Call - April 23, 2026

Stock Expert AI - Methodology

Do our scoring pillars, 6 perspectives, and Munger lens point in the same direction?

Historical V1 score 53 / 100

Historical V1 earnings-model score (archived, May 9, 2026) — not the current MoonshotScore. Current MoonshotScore: GL stock page

multi-pillar methodology. Cash Runway and Price Momentum strong. Revenue Growth weak.

How is it calculated? ->
Revenue Growth3.0Q1 vs Q2: moderate growth (+5.3%)
Gross Margin5.0Q1: average margin (49.4%)
Operating Leverage2.0op margin healthy (23.6%)
Cash Runway10.0FCF very strong ($0.4B, 15.9x CapEx)
R&D Intensity3.0low R&D investment (0.0%, weak innovation)
Price Momentum7.0RSI 54.0 balanced, 50d above
News Sentiment7.0strong buy consensus (73%)
Council Score 3 / 6 Bullish

6 investor frameworks. 3 bullish (Ray Dalio, Ken Griffin, Buffett), 0 bearish (none), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +13.5%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 54
Klarman value - target upside +13.5%
Buffett quality - ROE score 5/5
Munger valuation - target upside +13.5%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthStrong
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
54.0 RSI 54.0 balanced, 50d above
MACD
+3.90 price above 50d - support positive
50d MA
$145 stock 3.9% above - short-term support
200d MA
$140 stock 7.7% above - long-term support
Volume (10d)
-10% decrease - low participation
Resistance
$172
Analyst median target - upgrade trigger if broken
Current
$151
Pre-earnings position
Support
$119
Invalidation - close below this is a technical breakdown
Pattern
Range
$119-$172 band - earnings breakout/breakdown trigger

Past Performance

4 quarters shown.

BEAT
Q2 FY25
$3.27 vs $3.25 est · Next-day price move: +5.4%
BEAT
Q3 FY25
$4.81 vs $4.60 est · Next-day price move: +0.1%
MISS
Q4 FY25
$3.39 vs $3.44 est · Next-day price move: +1.5%
MISS
Q1 FY26
$3.43 vs $3.46 est · Next-day price move: +1.8%

Q1 FY26 (April 23, 2026) EPS $3.43 vs $3.46 estimate: miss (-0.9%)[FMP]. Stock move on D+1: +1.8%[FMP D+1].

Three scenarios: what could happen?

EPS < $3.57 (no guidance)

Q1 FY26 EPS $3.43 vs $3.46 estimate: miss (-0.9%)[FMP]. Stock move on D+1: +1.8%[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $24.9M[FMP cashflow]. Q1 op margin 23.6%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q2 EPS > $3.68 + CapEx discipline
Threshold: EPS > $3.68[FMP est].
Target: Break above median target $172[FMP target]; high target $185[FMP] upper bound.
Scenario B - In-Line
EPS approx $3.68 + CapEx < $24.9M
Threshold: EPS approx $3.68[FMP est], Q4 CapEx < $24.9M[FMP].
Target: Consolidation in the band between current $151[FMP] and median $172[FMP].
Scenario C - Miss
EPS < $3.57 or CapEx >= $24.9M
Threshold: EPS < $3.57[FMP estx0.97].
Current price $151 — above SMA200 $140 [FMP].

Market Outlook

What do analysts say? 2 price targets · 11 ratings

Wall Street Consensus
$172
12-month median target price (+13.5% gap to the analyst consensus median)
8
BUY
3
HOLD
0
SELL
Risk Management
$119
Invalidation level - critical support threshold
$145 - 50-day MA (above, +3.9%)
$140 - 200-day MA (above, +7.7%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - GL Q2 FY26
A

You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Wednesday evening. The framework is ready on this page: Q2 EPS threshold $3.68[FMP], CapEx threshold "below $24.9M". Two anchors, three scenarios.

Comparison Stock Expert AI is free today — no credit card.

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI is free today — no credit card. Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

See what's free GL dossier ->

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 22, 2026EARNINGSQ2 FY26 results (after market close) + earnings call
Jul 23, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Aug 9, 2026 – Aug 14, 2026FILING10-Q due within 40–45 days of quarter end (by Aug 9, 2026 – Aug 14, 2026); the exact deadline depends on filer status
~Oct 22, 2026EARNINGSQ3 FY26 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the GL Q2 FY26 earnings preview cover?

This Globe Life Inc. (GL) Q2 FY26 earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in GL Q2 FY26 earnings?

Globe Life Inc. (GL): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.

Where do the numbers on this page come from?

Globe Life Inc. (GL): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.

Is this a buy or sell recommendation?

Globe Life Inc. (GL): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.

More earnings, decoded